Potts shunt in patients with primary pulmonary hypertension

Sue Hyun Kim1, Woo-Sung Jang1, Hong-Gook Lim1

  • 1Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine.

Insights

Idiopathic pulmonary arterial hypertension (PAH) in children has high mortality. A Potts shunt procedure offered good short-term results for a 12-year-old girl with severe PAH and right ventricular failure.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Pulmonary Hypertension

Background:

  • Idiopathic pulmonary arterial hypertension (PAH) leads to right-sided heart failure and death, with high pediatric mortality.
  • Current pharmacological therapies have limited efficacy in improving outcomes for children with PAH.
  • Novel treatment strategies are crucial for managing pediatric PAH and improving survival.

Observation:

  • A 12-year-old girl presented with suprasystemic idiopathic pulmonary hypertension and significant right ventricular failure.
  • The patient underwent a Potts shunt procedure, creating an anastomosis between the left pulmonary artery and the descending aorta.
  • This palliative surgical technique aimed to alleviate the pressure on the right ventricle.

Findings:

  • The Potts shunt procedure resulted in good short-term outcomes for the patient.
  • The surgical intervention provided immediate palliation for the severe symptoms of pediatric PAH.
  • This case demonstrates the potential benefit of the Potts shunt in managing complex pediatric cardiovascular conditions.

Implications:

  • The Potts shunt may serve as a viable palliative option for select pediatric patients with refractory idiopathic pulmonary arterial hypertension.
  • Further research is warranted to evaluate the long-term efficacy and safety of the Potts shunt in this population.
  • This case highlights the importance of considering surgical interventions for severe pediatric cardiovascular diseases when medical management is insufficient.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
898
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.6K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
804
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.4K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.2K
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
395